Shree Ahimsa Naturals Limited is launching its IPO, set to open for bidding from 25th March 2025 and closing on 27th March 2025. With a book-built issue of 62,02,800 shares amounting to ₹73.81 crore, including a fresh issue of 42,03,600 shares worth ₹50.02 crore, the IPO has attracted significant market attention. This detailed analysis aims to provide comprehensive insights into the company’s financial health, valuation, IPO specifics, potential risks, and investment considerations.
Company Overview
Incorporated in 1990, Shree Ahimsa Naturals Limited specializes in manufacturing and extracting caffeine anhydrous, green coffee bean extracts, crude caffeine, and herbal extracts. The company operates as a 100% Export Oriented Unit (EOU), benefiting from favorable trade regulations. SANL maintains rigorous quality management practices, holding ISO 22000 Food Safety Management System and ISO 45001 Occupational Health & Safety Management certifications, indicative of its commitment to quality standards.
IPO Details at a Glance
- IPO Dates: 25th March – 27th March 2025
- Allotment Date: 28th March 2025
- Listing Date: 2nd April 2025
- Issue Size: 62,02,800 shares (₹73.81 crore)
- Fresh Issue: 42,03,600 shares (₹50.02 crore)
- Price Band: ₹113-₹119 per share
- Lot Size: 1,200 shares (₹1,42,800)
- Listing Exchanges: NSE and SME
- Registrar: Cameo Corporate Services Limited
Financial Performance Analysis
An in-depth financial review reveals mixed signals regarding SANL’s recent performance. During FY23-24, the company reported revenues of ₹78.70 crore, marking a notable decrease of 25.85% from the previous year’s ₹106.14 crore. Furthermore, profitability (PAT) sharply declined by 51.13%, falling from ₹38.21 crore to ₹18.67 crore.
Despite the recent downturn, a broader historical review indicates that SANL has maintained a generally positive financial trajectory. For example, revenue growth from ₹58.94 crore in FY21-22 to ₹106.14 crore in FY22-23 highlights strong operational capabilities prior to the recent decline.
Key Financial Metrics
- EPS (Pre-IPO): ₹9.76
- EPS (Post-IPO): ₹8.35
- PE Ratio (Pre-IPO): 12.19
- PE Ratio (Post-IPO): 14.25
- RoNW: 22.25%
- ROCE: 25.69%
- Market Cap: ₹277.63 crore
These indicators suggest a reasonably valued IPO, particularly given a PE ratio of 12.19 pre-IPO. However, the increasing post-IPO PE ratio indicates potential valuation concerns once the new equity is factored in.
GMP and Market Sentiment
The Grey Market Premium (GMP) has indicated steady investor confidence ahead of the IPO, maintaining a premium of ₹10 per share on the upper price band. This GMP suggests an estimated listing price of ₹129 per share, implying a possible 8.40% listing gain.
Recent GMP trends:
- 24-03-2025: ₹10 (₹129 Estimated Listing Price)
- 23-03-2025: ₹10
- 21-03-2025: ₹3
- 20-03-2025: ₹0
The strengthening GMP indicates rising positive sentiment as the IPO approaches, reflective of investor optimism despite recent financial declines.
Reservation Breakdown
The IPO is structured with clear investor allocations:
- Qualified Institutional Buyers (QIBs): up to 50%
- Retail Investors: at least 35%
- Non-Institutional Investors (NIIs): at least 15%
Strengths and Opportunities
- Export-Oriented Advantage: As a 100% EoU, SANL leverages favorable international trade policies and benefits from broader market access, potentially driving revenue growth through global demand.
- Established Client Base: SANL maintains strong, longstanding customer relationships, providing consistent revenue streams and stability.
- Robust Infrastructure and Certifications: The company’s sophisticated manufacturing facilities, supported by advanced R&D capabilities and industry-recognized certifications, enhance product quality, allowing SANL to command competitive pricing.
- Experienced Management Team: Led by promoters with decades of industry experience, SANL benefits from strategic insights and effective management practices critical for sustained growth.
Risks and Concerns
- Recent Decline in Financial Performance: The substantial decline in both revenue and profit in FY23-24 raises concerns about market competitiveness and operational efficiency.
- Low Market Capitalization: A market capitalization of ₹277.63 crore positions SANL within the smaller segment, potentially limiting institutional investor interest and affecting stock liquidity.
- High Lot Size: The minimum investment of ₹1,42,800 (1,200 shares) may deter small retail investors, narrowing investor base and market participation.
- Competitive Industry: Operating in the natural extracts industry, SANL faces intense competition both domestically and internationally, possibly impacting margins and market share.
Objectives of the IPO
SANL aims to utilize IPO proceeds to:
- Establish a new manufacturing unit in Sawarda, Jaipur, Rajasthan, significantly enhancing its production capacity.
- Fund general corporate purposes, including operational expansion, debt management, and strategic investments.
Promoter Holding Analysis
Pre-IPO promoter holding stands robust at 94.22%, indicative of promoters’ significant commitment. Post-IPO equity dilution will alter this holding structure, but promoters will maintain a substantial stake, ensuring aligned interests with investors.
Subscription Expectations
Given the recent positive GMP trends and market sentiment, the IPO is anticipated to witness decent demand, especially from retail investors attracted by potential listing gains. QIB and NII categories are also likely to see participation based on SANL’s fundamental strengths.
Investment Considerations
Investor decision-making should weigh several factors carefully:
- Short-Term Prospects: Favorable GMP suggests immediate potential gains, making SANL IPO attractive for listing gains.
- Medium to Long-Term View: Investors seeking stability and long-term appreciation must consider risks associated with recent profitability declines and competitive pressures.
- Risk Appetite: Given SANL’s smaller market cap and higher lot size, investors must assess their risk tolerance and liquidity preferences.
Expert Opinions
According to industry analyst Dilip Davda from Chittorgarh Infotech, SANL IPO is “reasonably priced” and shows sustainable trends for top- and bottom-line growth over the medium to long term. However, caution is advised due to recent profit declines, which should be carefully evaluated against potential growth prospects post-IPO.
Conclusion
Shree Ahimsa Naturals IPO presents a balanced opportunity, offering potential short-term gains, driven by positive market sentiment and GMP. However, investors must remain mindful of the recent downturn in the company’s financial performance and the competitive industry landscape.
Long-term investors should thoroughly assess the company’s strategic plans to utilize IPO proceeds for capacity expansion, as success in executing these initiatives will significantly influence future profitability and market standing.
Overall, the IPO warrants consideration for investors seeking exposure to the niche segment of caffeine and herbal extracts, provided they adopt a cautious and well-informed investment approach, balancing immediate listing gains with long-term growth potential and associated risks.
ALSO READ: Quality Power IPO: All You Need to Know
